Hyperbaric Oxygen Therapy as adjunctive treatment of chronic diabetic foot ulcers
Abstract: Chronic diabetic foot ulcers are a source of major concern for both patients and health care systems. Oxygen deficiency plays a major role in the pathogenesis of these ulcers. Hyperbaric oxygen therapy (HBOT) has been proposed as a medical treatment for diabetic foot ulcers, but the clinical utility has not been established. Hyperbaric Oxygen in Diabetic patients with chronic Foot Ulcer (HODFU) study is a prospective, randomized, placebo-controlled, double-blinded study, evaluating the effect of HBOT on ulcer healing in diabetic patients with chronic foot ulcers. Ninety four patients were included, representing 74% of all patients fulfilling the medical inclusion criteria during the inclusion period. Adjunctive HBOT significantly improved foot ulcer healing at 9- and 12-months follow-ups as compared to placebo. Numbers-needed to treat to avert non-healing of a chronic foot ulcer was 3.1. Treatment was well-tolerated and frequencies of adverse events were low. TcPO2, but not toe-blood pressure or ankle-brachial index, was identified as prognostic marker for ulcer healing after HBOT. At one-year follow-up HBOT was associated with improved health related quality of life. Patients perceived HBOT as unproblematic but time-consuming. Evaluation of these patients cardiac function indicates that a chronic diabetic foot ulcer should be regarded as a marker of cardiac disease. Thus, pharmacological cardiovascular prevention ought to be considered in all patients with a chronic diabetic foot ulcer. In conclusion, this study supports the concept that adjunctive treatment with HBOT enhances foot ulcer healing in selected patients with diabetes.
This dissertation MIGHT be available in PDF-format. Check this page to see if it is available for download.